Browsing Tag
Etripamil
2 posts
Milestone takes etripamil into Phase 3 AFib test with at-home treatment strategy
Milestone Pharmaceuticals has dosed the first patient in a pivotal Phase 3 trial testing whether etripamil nasal spray can give patients with rapid-rate atrial fibrillation an at-home alternative to emergency treatment.
Milestone Pharmaceuticals (NASDAQ: MIST) gets FDA green light for etripamil nasal spray
Discover how Milestone Pharmaceuticals’ FDA approval of CARDAMYST (etripamil) is reshaping PSVT treatment and setting the stage for broader cardiovascular care. Read more.